Sign in

CIK 0000744218

  • Large accelerated filer

Celldex Therapeutics, Inc.

Sign in to watch
Ticker
CLDX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
133191702
Phone
+1 908-200-7500
Business address
53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ, 08827
Former names
AVANT IMMUNOTHERAPEUTICS INC, T CELL SCIENCES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 73 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2014-06-04 LIPTON KAREN SHOOS Director Grant or award +2,000 15,333
2014-06-04 LIPTON KAREN SHOOS Director Grant or award · Non-Qualified Stock Option (right to buy) +2,000 2,000
2014-06-04 PENNER HARRY JR Director Grant or award +2,000 15,416
2014-06-04 PENNER HARRY JR Director Grant or award · Non-Qualified Stock Option (right to buy) +2,000 2,000
2014-06-04 ELLBERGER LARRY Director Grant or award +2,000 27,000
2014-06-04 ELLBERGER LARRY Director Grant or award · Non-Qualified Stock Option (right to buy) +2,000 2,000
2014-06-04 CATLIN AVERY W Sr. VP & CFO Grant or award · Incentive Stock Option +92,000 92,000
2014-06-04 PEPIN RONALD Sr. VP & CBO Grant or award · Incentive Stock option +92,000 92,000
2014-06-04 Davis Thomas Andrew Sr. VP & CMO Grant or award · Incentive Stock Option +116,500 116,500
2014-06-04 KELER TIBOR Sr. VP & CSO Grant or award · Incentive Stock Option +116,500 116,500
2014-06-04 Marucci Anthony S President & CEO Grant or award · Incentive Stock Option +280,000 280,000
2013-12-06 LIPTON KAREN SHOOS Director Exercise or conversion +17,728 $8.16 $145K 31,061
2013-12-06 LIPTON KAREN SHOOS Director Sale −17,728 $24.50 $434K 13,333
2013-12-06 LIPTON KAREN SHOOS Director Exercise or conversion · Non-Qualified Stock Option −17,728 0
2013-12-06 PENNER HARRY JR Director Exercise or conversion +17,728 $8.16 $145K 31,144
2013-12-06 PENNER HARRY JR Director Sale −17,728 $24.50 $434K 13,416
2013-12-06 PENNER HARRY JR Director Exercise or conversion · Non-Qualified Stock Option −17,728 0
2013-12-06 ELLBERGER LARRY Director Exercise or conversion +17,728 $8.16 $145K 42,728
2013-12-06 ELLBERGER LARRY Director Sale −17,728 $24.50 $434K 25,000
2013-12-06 ELLBERGER LARRY Director Exercise or conversion · Non-Qualified Stock Option −17,728 0

Page 23 of 32 · 629 trades